LSE •
Healthcare •
Biotechnology •
Quote as of 05/08/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization20.49 mln
Float2,187 mln
Earnings Date10/20/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.98
Likely reliable
Relative Strength
78
/ 100
Strongly outperforming
Debt / Equity
0.15
Very low leverage
ROE
-119
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in 2008 and based in York, UK, Aptamer Group develops and supplies specialized molecules called aptamers that can be designed to attach to specific biological targets. These molecules serve a wide range of industries, from drug development and medical testing to cosmetics and consumer health products. The company works with major organizations including AstraZeneca, Unilever, and several academic institutions, selling its solutions to clients across Europe, the United States, and beyond.
